800-977-5614

Benicar Lawsuits Continue to Grow

November 4, 2014

November 4, 2014 On June 17, 2014, California resident Susanne Ambler and her husband filed a lawsuit against Daichi Sankyo for injuries Ms. Ambler suffered while taking Benicar, a product manufactured by Daiichi Sankyo. Benicar was approved by the FDA in 2002 for use in the treatment of hypertension. According to court filings, Ambler claims that she suffered sprue-like enteropathy symptoms which resulted in numerous hospitalizations. Her case was transferred to federal court with a final pretrial conference scheduled for December of this year. In Texas, another Benicar lawsuit was filed by George Williams against Daiichi Sankyo and Forest Laboratories, … More

U.S. Judicial Panel on Multidistrict Litigation to hear Oral Arguments regarding Xarelto

November 3, 2014

On July 25, 2014, the McGowen family filed a claim in the U.S. District Court for the District of Vermont against Xarelto drug manufacturer, Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary for the wrongful death of Thomas C. Dunkley. Mr. Dunkley was diagnosed as suffering from atrial fibrillation, a heart-related disease that is characterized by an irregular and often rapid heart rate that usually causes reduced blood flow to the body. For his condition, Dunkley was prescribed Xarelto (rivaroxaban) to treat atrial fibrillation to reduce his risk of sustaining an embolic stroke. Dunkley passed away less than two … More

Maryland Appeals Court Revives Medtronic Infuse Injury Suit

October 28, 2014

The Maryland Court of Special Appeals recently revived a medical device products liability case, ruling that the claim was not preempted by federal law. The personal injury claims, brought by Steven McCormick together with his wife, arose from the so-called “off-label” promotion of a medical device, called the Infuse Bone Graft. Manufactured by defendant Medtronic, the device left McCormick disabled and unemployed allegedly due to this improper “off-label” use. The Infuse Bone Graft was developed by Medtronic and was approved by the FDA in 2002. The three components of the device consist of: A genetically-engineered protein that stimulates bone growth. … More

Texas Jury awards $73 Million in Pelvic Mesh Case

September 19, 2014

A 12-person jury on Sept. 8 ordered Boston Scientific Corp. to pay a Texas woman $73 million after finding the company negligent in both the design and marketing of its Obtryx transvaginal mesh sling. The case, Salazar vs. Lopez, was the first to go to trial against Boston Scientific in Texas state court, and the first to render a verdict against the company — a hopeful sign for thousands of woman bringing similar product liability lawsuits in state and federal courts across the country. The jury’s award included $50 million in punitive damages, far exceeding amounts awarded in previous pelvic … More

Special report: The dangers of painkillers

August 17, 2014

https://www.consumerreports.org/cro/video-hub/3705124027001/ Every year, Percocet, Vicodin, and other opioids kill 17,000 Americans and acetaminophen sends 80,000 people to the ER America is in pain—and being killed by its painkillers. It starts with drugs such as OxyContin, Percocet, and Vicodin—prescription narcotics that can make days bearable if you are recovering from surgery or suffering from cancer. But they can be as addictive as heroin and are rife with deadly side effects. Use of those and other opioids has skyrocketed in recent years. Prescriptions have climbed 300 percent in the past decade, and Vicodin and other drugs containing the narcotic hydrocodone are now … More

Johnson & Johnson recalls hysterectomy power morcellator that may spread cancer

August 13, 2014

Healthcare company Johnson & Johnson announced that it will stop the sale and distribution of its power morcellators after the Food and Drug Administration (FDA) discouraged its use for hysterectomy, or the removal of the uterus, and myomectomy, the removal of uterine fibroids, as the use of the device could spread undetected cancer. More

FDA bans generic versions of original OxyContin pills

July 10, 2014

(CNN) – In an effort to curb prescription painkiller abuse, the Food and Drug Administration is banning generic versions of the original OxyContin formula. “The FDA has determined that the benefits of original OxyContin no longer outweigh its risks,” the agency said in a statement. Read More at the article source on CNN. More

FDA probes new pancreas risks with diabetes drugs

July 10, 2014

WASHINGTON (AP) — The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems. The agency said Thursday samples of pancreas tissue taken from a small number of patients showed inflammation and cellular changes that often precede cancer. Academic researchers took the samples from diabetes patients who were taking the new medications, after they died from various causes. Read More at the article source: Yahoo News. More

FDA: Popular antibiotic can cause fatal heart rhythms

July 10, 2014

(CNN) – A popular antibiotic used to treat bacterial infections can cause abnormal — and possibly fatal — heart rhythms in some patients, according to a new warning from the Food and Drug Administration. The drug, azithromycin, sells under the name Zithromax or Zmax and is commonly sold in what’s called a Z-Pak. Full Article More

Tylenol cases – short form complaint – questionnaire

July 10, 2014

Please download here: Tylenol Short Form Complaint and Tylenol Questionnaire. More